Although RNA vaccines have numerous benefits, they also face several challenges. One of the main issues is the requirement for ultra-cold storage conditions, making distribution and logistical management more complex, especially in low-resource settings. Another challenge is the potential for rapid degradation of mRNA, necessitating the use of lipid nanoparticles to protect the mRNA molecules until they reach the target cells.
